RhumbLine Advisers’s Tevogen Inc TVGN Stock Holding History

RhumbLine Advisers’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,003	Closed	-$4.53K	–	4271
2026 Q1	$4.53K	Buy	1,003 +437	+77%	+$5.36K	﹤0.01%	3884
2025 Q4	$9.37K	Buy	566 +149	+36%	+$3.87K	﹤0.01%	3861
2025 Q3	$16.4K	Sell	417 -45	-10%	-$2.21K	﹤0.01%	3801
2025 Q2	$28.8K	Sell	462 -129	-22%	-$7.35K	﹤0.01%	3753
2025 Q1	$31.9K	Buy	591 +124	+27%	+$8.16K	﹤0.01%	3662
2024 Q4	$24.1K	Buy	467 +76	+19%	+$4.95K	﹤0.01%	3776
2024 Q3	$7.19K	Sell	391 -4	-1%	-$117	﹤0.01%	3934
2024 Q2	$14.3K	Buy	+395	New	+$25.7K	﹤0.01%	3922

Other funds holding TVGN

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

RhumbLine Advisers's TVGN Position: Q2 2026 in Review

RhumbLine Advisers sold out of Tevogen Inc (TVGN) in Q2 2026, closing a stake of 1,003 shares — an estimated $4.53K sold.

RhumbLine Advisers first reported a position in TVGN in Q2 2024 and held it in 8 quarters. The position peaked at $31.9K in Q1 2025. 31 funds tracked by Wall St. Rank hold TVGN as of Q2 2026.

RhumbLine Advisers reported no remaining Tevogen Inc position as of Q2 2026 after selling out during the quarter.
RhumbLine Advisers sold 1,003 Tevogen Inc shares in Q2 2026, an estimated $4.53K.
RhumbLine Advisers first reported a position in Tevogen Inc in Q2 2024 and held it in 8 quarters.
RhumbLine Advisers's Tevogen Inc position peaked at $31.9K in Q1 2025.
31 funds tracked by Wall St. Rank held Tevogen Inc as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.